Literature DB >> 23062632

Measuring the burden of disease and injury in Spain using disability-adjusted life years: an updated and policy-oriented overview.

R Gènova-Maleras1, E Álvarez-Martín, C Morant-Ginestar, N Fernández de Larrea-Baz, F Catalá-López.   

Abstract

OBJECTIVE: To provide a comprehensive and detailed overview of the burden of disease in Spain for 2008. Implications for public health policies are discussed. STUDY
DESIGN: Cross-sectional population-based study.
METHODS: Disability-adjusted life years (DALYs) were calculated at country level using the methodology developed in the Global Burden of Disease study. DALYs were divided into years of life lost and years of life lived with disability. Results were obtained using Spanish mortality data for 2008 and morbidity data estimated previously by the World Health Organization for Euro-A.
RESULTS: In 2008, DALYs lost due to all diseases and injuries were estimated at 5.1 million. Non-communicable diseases accounted for 89.2% of the total DALYs. The leading causes of DALYs were neurological and mental disorders (29.9%), malignant neoplasms (15.8%) and cardiovascular diseases (12.5%). The main specific causes included depression (5.5%), ischaemic heart disease (5.5%), lung cancer (5.3%) and alcohol abuse (4.7%) among males; and depression (11.7%), dementias (10.0%), hearing loss (4.2%) and cerebrovascular disease (3.5%) among females.
CONCLUSIONS: Measuring DALYs specifically for Spain represents a systematic analysis of population health losses, and also provides an important measure to track the outcomes of future health interventions.
Copyright © 2012 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23062632     DOI: 10.1016/j.puhe.2012.08.012

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  7 in total

Review 1.  The global impact of non-communicable diseases on macro-economic productivity: a systematic review.

Authors:  Layal Chaker; Abby Falla; Sven J van der Lee; Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2015-04-03       Impact factor: 8.082

Review 2.  Cost of disorders of the brain in Spain.

Authors:  Oleguer Parés-Badell; Gabriela Barbaglia; Petra Jerinic; Anders Gustavsson; Luis Salvador-Carulla; Jordi Alonso
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

3.  The Economic Burden of Brain Disability in Korea, 2008-2011.

Authors:  Hyun-Jin Kim; Seung Hee Ho; Sol Lee; In-Hwan Oh; Ju Hee Kim; Eun Joo Kim; Seong Jae Lee
Journal:  Inquiry       Date:  2020 Jan-Dec       Impact factor: 1.730

4.  [Potential sponsorship bias in cost-effectiveness analyses of healthcare interventions: A cross-sectional analysis].

Authors:  Ferrán Catalá-López; Manuel Ridao
Journal:  Aten Primaria       Date:  2017-01-03       Impact factor: 1.137

5.  Spatial distribution and determinants of health loss from Kashin-Beck disease in Bin County, Shaanxi Province, China.

Authors:  Jing Wang; Xiaoya Wang; Hairong Li; Linsheng Yang; Yingchun Li; Chang Kong
Journal:  BMC Public Health       Date:  2021-02-19       Impact factor: 3.295

6.  Associations between Physical Activity Level and Mental Health in the Spanish Population: A Cross-Sectional Study.

Authors:  Ángel Denche-Zamorano; Sabina Barrios-Fernandez; Rafael Gómez-Galán; Juan Manuel Franco-García; Jorge Carlos-Vivas; María Mendoza-Muñoz; Jorge Rojo-Ramos; Alejandro Vega-Muñoz; Nicolás Contreras-Barraza; Konstantinos Gianikellis; Laura Muñoz-Bermejo
Journal:  Healthcare (Basel)       Date:  2022-08-01

7.  The burden of disease in Spain: results from the global burden of disease study 2010.

Authors:  Josep Maria Haro; Stefanos Tyrovolas; Noe Garin; Cesar Diaz-Torne; Loreto Carmona; Lidia Sanchez-Riera; Fernando Perez-Ruiz; Christopher J L Murray
Journal:  BMC Med       Date:  2014-12-05       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.